Blog
Researchers Observe Bidirectional Association of Alopecia Areata, MDD In Siblings
Dermatology Advisor reports, “Unaffected siblings of probands with alopecia areata and/or major depressive disorder are also at increased risk for developing alopecia or depression compared with control patients,” investigators concluded in a study that “included 2123 probands with alopecia areata, 2298 unaffected siblings, and 9192 matched control patients who were assessed for risk for major depressive disorder [MDD],” as well as “16,543 probands with depression, 17,352 unaffected siblings, and 69,408 matched control patients were assessed for risk for developing alopecia areata.” The findings were published in the Journal of the American Academy of Dermatology.
Post Views: 256
Related Posts
New Hope for Teens Facing Sudden Hair Loss
New clinical results suggest that treatments already helping adults with severe alopecia
Leqselvi – FDA Approved for Severe Alopecia Areata
In July 2024, the U.S. FDA approved Leqselvi™ (deuruxolitinib) as a treatment for adults with severe alopecia areata. Developed by...
Stress Re-Confirmed as a Major Factor in Hair Loss
A study published in December 2024 confirmed that stress can lead to conditions like telogen effluvium and alopecia areata, causing...
The Scalp Care Surge
A Vital Ecosystem for Hair Health
Scalp Health: The Root of Vibrant, Healthy Hair
In the evolving market for beauty and personal...
FDA Halts Trial of Hair Loss Drug
Natural Solutions Gaining Traction as Safer Alternatives
The US Food and Drug Administration (US FDA) has recently placed a partial clinical...
Understanding Hair
HAIR AS A SKIN APPENDAGE
By Marta Teixeira
Introduction
There are a range of significant symptoms related to hair and scalp disorders that...
NYC Dermatologist launches first Anti-Aging Wellness Program
The new physician and nutritionist-led Anti-Aging Wellness Program utilizes a 360° approach to aesthetics and longevity, designed to empower patients...
FDA Approves First Systemic Treatment for Alopecia Areata
June 2022 - Today, the U.S. Food and Drug Administration approved Olumiant (baricitinib) once a day oral tablets to treat...
Understanding Hair
General description of hair as a skin appendage By Marta Teixeira
This article will look at the general description of hair...
Hair and nail manifestations of COVID-19
Abstract
Emerging literature evidence shows that the manifestations of the coronavirus disease 2019 (COVID-19), which is the disease caused by SARS-CoV-2,...
Consensus on Trichology Treatments from a Panel of Experts
Treatment advancements for trichology, or hair disorders, have not been recently evaluated and therefore lack consensus on their safety and...
Video Calls are making is more self conscious about our appearance
Whether it’s for work or to stay in touch with friends and family, nearly everyone is spending more time looking...